Literature DB >> 11890884

Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy.

Mishaela R Rubin1, Shonni J Silverberg.   

Abstract

A frequent manifestation of severe primary hyperparathyroidism was the bone disease osteitis fibrosa cystica. Rarely, excess parathyroid hormone (PTH) was associated with gout and calcium pyrophosphate crystal deposition disease. Surgical cure of primary hyperparathyroidism was occasionally associated with pseudogout. Today, primary hyperparathyroidism is generally asymptomatic. Clinically overt rheumatologic and skeletal effects are mainly of historical interest. Skeletal disease is still detectable by more sensitive techniques. In certain circumstances, PTH may be protective and anabolic for the skeleton.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890884     DOI: 10.1007/s11926-002-0014-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  61 in total

1.  A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.

Authors:  H Jüppner; A B Abou-Samra; M Freeman; X F Kong; E Schipani; J Richards; L F Kolakowski; J Hock; J T Potts; H M Kronenberg
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

2.  Clinical studies of acute pseudogout attacks: comments on prevalence, predispositions, and treatment.

Authors:  J D O'Duffy
Journal:  Arthritis Rheum       Date:  1976 May-Jun

3.  Pseudogout as a clue and complication in primary hyperparathyroidism.

Authors:  G W Geelhoed; T R Kelly
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

4.  Primary hyperparathyroidism: clinical and biochemical features.

Authors:  L E Mallette; J P Bilezikian; D A Heath; G D Aurbach
Journal:  Medicine (Baltimore)       Date:  1974-03       Impact factor: 1.889

5.  Diseases associated with calcium pyrophosphate dihydrate crystal deposition.

Authors:  D J McCarty; D C Silcox; F Coe; S Jacobelli; E Reiss; H Genant; M Ellman
Journal:  Am J Med       Date:  1974-05       Impact factor: 4.965

Review 6.  Anabolic actions of parathyroid hormone on bone.

Authors:  D W Dempster; F Cosman; M Parisien; V Shen; R Lindsay
Journal:  Endocr Rev       Date:  1993-12       Impact factor: 19.871

7.  Acute arthritis. A complication of surgically induced hypoparathyroidism.

Authors:  W V Sharp; T R Kelly
Journal:  Am J Surg       Date:  1967-06       Impact factor: 2.565

8.  Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro.

Authors:  B A Derfus; J W Rachow; N S Mandel; A L Boskey; M Buday; V M Kushnaryov; L M Ryan
Journal:  Arthritis Rheum       Date:  1992-02

9.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium.

Authors:  A B Abou-Samra; H Jüppner; T Force; M W Freeman; X F Kong; E Schipani; P Urena; J Richards; J V Bonventre; J T Potts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis.

Authors:  M Parisien; R W Mellish; S J Silverberg; E Shane; R Lindsay; J P Bilezikian; D W Dempster
Journal:  J Bone Miner Res       Date:  1992-08       Impact factor: 6.741

View more
  5 in total

1.  Is there any association between primary hyperparathyroidism and ocular changes, such as central corneal thickness, retinal thickness, and intraocular pressure?

Authors:  Husniye Baser; Neslihan Cuhaci; Oya Topaloglu; Fatma Yulek; Nagihan Ugurlu; Reyhan Ersoy; Nurullah Cagil; Bekir Cakir
Journal:  Endocrine       Date:  2015-08-29       Impact factor: 3.633

2.  Prevalence of primary hyperparathyroidism in a referred sample of fibromyalgia patients.

Authors:  Robert Ferrari; Anthony Science Russell
Journal:  Clin Rheumatol       Date:  2014-07-03       Impact factor: 2.980

Review 3.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 4.  Comorbidities in patients with crystal diseases and hyperuricemia.

Authors:  Sebastian E Sattui; Jasvinder A Singh; Angelo L Gaffo
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

5.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.